Jason Hampson
General Counsel bij KINNATE BIOPHARMA INC.
Profiel
Jason Hampson is currently the Vice President & Head-Regulatory Affairs at Kinnate Biopharma, Inc. He previously worked as the Director-Regulatory Affairs at Amgen, Inc. Hampson completed his undergraduate degree at the University of the West of England.
Actieve functies van Jason Hampson
| Bedrijven | Functie | Begin |
|---|---|---|
| KINNATE BIOPHARMA INC. | General Counsel | 07-06-2021 |
Eerdere bekende functies van Jason Hampson
| Bedrijven | Functie | Einde |
|---|---|---|
| AMGEN INC. | General Counsel | 01-05-2021 |
Opleiding van Jason Hampson
| University of the West of England | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
